fda ends semaglutide shortage shortage semaglutide The shortage of semaglutide injections (#Ozempic, #Wegovy) is over, the FDA announcedopens in Makers of compounded Wegovy, Ozempic

Its mechanism of action, targeting the incretin system, addresses both the metabolic dysfunction in diabetes and the behavioral aspects of obesity, such as overeating

These include severe abdominal pain suggesting pancreatitis, persistent vomiting leading to dehydration, or signs of thyroid nodules

(Quick refresher on what FDA-cleared means: A device has undergone a 510(k) submission thats been accepted with the conclusion that it wont cause harm and is as safe and effective as another legally marketed device

Youll slowly increase your dose every 4 weeks until you reach 7.2mg (the maintenance or maximum dose of Wegovy)